An isolated event involving the termination of the U.S. license agreement with Helsinn Healthcare for Aloxi. It covers the termination of the U.S. licensing relationship separately from patent litigation and generic product launches.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.